LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study

By Jukema J. Wouter   Liem An-Ho   Dunselman Peter H. J. M.   van der Sloot Jos A. P.   Lok Dirk J. A.   Zwinderman Aeilko H.  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1865-1874

Informa Healthcare

Access to resources Recommend Favorite

Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes*

By van Hoek M.   van Tol A.   van Vark-van der Zee L. C.   Jansen H.   Kastelein J. J. P.   Sijbrands E. J. G.   Dallinga-Thie G. M.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 93-101

Informa Healthcare

Access to resources Recommend Favorite

Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia

By Paragh G.   Törőcsik D.   Seres I.   Harangi M.   Illyés L.   Balogh Z.   Kovács P.  

Current Medical Research and Opinion, Vol. 20, Iss. 8, 2004-08 ,pp. : 1321-1327

Informa Healthcare

Access to resources Recommend Favorite

ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management*

By de Nijs Tjerk   Sniderman Allan   de Graaf Jacqueline  

Critical Reviews in Clinical Laboratory Sciences, Vol. 50, Iss. 6, 2013-11 ,pp. : 163-171

Informa Healthcare

Access to resources Recommend Favorite

A health economic model to determine the long-term costs and clinical outcomes of raising low HDL-cholesterol in the prevention of coronary heart disease

By Roze S.   Liens D.   Palmer A.   Berger W.   Tucker D.   Renaudin C.  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2549-2556

Informa Healthcare

Access to resources Recommend Favorite